Thrombosis and Thrombophilia


Thrombosis and Thrombophilia

What are thrombosis and thrombophilia?

Thrombosis occurs when a blood clot, or thrombus, forms inside a vein or artery and may obstruct normal blood flow. In the venous system, the most common forms are deep vein thrombosis (DVT), usually in the leg, and pulmonary embolism (PE), which occurs when part of a clot breaks away and travels to the lungs. Both are included under the term venous thromboembolism.

Thrombophilia is an increased tendency for the blood to clot due to changes in the body’s clotting mechanisms. It can make thrombosis more likely, but the two are different: thrombosis is the formation of a clot, while thrombophilia is a condition that increases the chance of a clot forming.

Having thrombophilia does not mean a person will necessarily develop thrombosis. Many people with thrombophilia never have a blood clot.

📌 Statistical context: In many populations, venous thromboembolism occurs in approximately 1–2 out of every 1,000 people each year. According to some estimates, about 1 in 20 people may experience at least one episode during their lifetime.


How do thrombosis and thrombophilia develop?

Normally, blood remains fluid inside the vessels and clots when needed—for example, after an injury to stop bleeding. Clotting factors, which promote clot formation, and natural anticoagulants, which limit it, maintain this balance. Thrombosis and thrombophilia both involve a disruption of this balance, but in different ways.

How does thrombosis develop?

Thrombosis occurs when clotting is activated inappropriately inside a blood vessel. Three mechanisms often act together: slowed blood flow, damage to the vessel wall, and an increased tendency for blood to clot. Their combined effect helps explain why thrombosis can occur after surgery, during immobilization, or at other times of increased risk.

Once a clot forms, its effects depend on its location. If it blocks a deep vein, blood can back up in the limb and cause swelling and pain. If part of the clot breaks away and travels to the lungs, it can block pulmonary blood flow and cause a potentially life-threatening pulmonary embolism.

How does thrombophilia develop?

Thrombophilia is not an event like thrombosis. It is a condition that increases the tendency of blood to clot. In inherited forms, genetic changes affect clotting factors or their natural inhibitors. In acquired forms, this tendency develops during life; antiphospholipid syndrome is an important example.

Thrombophilia often causes no signs on its own. The risk of thrombosis increases particularly when another factor is present, such as surgery, immobilization, pregnancy, or estrogen use.


Main causes

Causes of thrombosis

Thrombosis rarely has just one cause. It usually results from an interaction between an individual predisposition and one or more additional factors. Three groups of mechanisms contribute to clot formation:

  • Slowed blood flow: Bed rest, immobilization of a limb, paralysis, or long-distance travel can slow the flow of blood.
  • Vessel damage: Major surgery, trauma, fractures, or venous catheters may damage the vessel wall.
  • Increased tendency to clot: This may be associated with thrombophilia, pregnancy, estrogen use, cancer, or certain inflammatory diseases.

Causes of thrombophilia

Inherited thrombophilia is associated with genetic changes present from birth. Acquired thrombophilia develops during life as a result of a particular condition, especially antiphospholipid syndrome. Cancer, surgery, and immobilization are also important risk factors for thrombosis, but they should not automatically be confused with a diagnosis of thrombophilia.


Risk factors

The risk of thrombosis rises when several factors act together. Thrombophilia is one of these factors; others may be temporary or ongoing.

Risk factors for thrombosis

  • A previous thrombosis or a family history of thrombosis
  • Major surgery, hospitalization, prolonged bed rest, a cast, or immobilization
  • Trauma and fractures, particularly of the pelvis and lower limbs
  • Pregnancy and the postpartum period
  • Estrogen-containing contraceptives or hormone therapy
  • Cancer and its treatment, inflammatory diseases, obesity, and older age
  • Long-distance travel, especially when combined with immobility and other risk factors

What determines thrombophilia?

Inherited thrombophilia is associated with genetic changes such as factor V Leiden, the prothrombin variant, or deficiencies of antithrombin, protein C, or protein S.

Acquired thrombophilia is linked to a condition that develops during life, such as antiphospholipid syndrome. Its evaluation is based on the clinical history and relevant tests.

Pregnancy, estrogen use, surgery, and immobilization increase the risk of thrombosis. In someone with known thrombophilia, they may increase that risk further.


Types of thrombosis and thrombophilia

Types of thrombosis

Depending on the vessel affected, thrombosis may be venous or arterial. Venous thromboembolism includes two main conditions:

  • Deep vein thrombosis (DVT): A clot usually forms in the deep veins of the leg or pelvis.
  • Pulmonary embolism (PE): Part of a clot breaks away and blocks blood flow in the lungs.

Types of thrombophilia

Thrombophilia may be inherited or acquired.

Inherited thrombophilia

Inherited thrombophilias are genetic changes that increase the risk of venous thrombosis. However, many people who carry them never develop a clot: the genetic change increases risk but often is not enough on its own.

  • Factor V Leiden: This is among the most common forms of inherited thrombophilia. The altered factor V resists being switched off by activated protein C, so clotting continues longer than it should. In people who carry one copy of the variant, the relative risk of venous thrombosis is several times higher, but individual risk also depends on other factors.
  • Prothrombin variant (G20210A): This may lead to higher prothrombin levels in the blood and increase the tendency to clot.
  • Antithrombin deficiency: This is rare but can be associated with a high risk because antithrombin is a natural inhibitor of clotting. Assessment is particularly important in circumstances such as pregnancy.
  • Protein C or protein S deficiency: These deficiencies reduce the natural inhibition of clotting. Levels of these proteins can also be affected by a person’s clinical condition or certain anticoagulants, so testing needs to be timed appropriately.
  • MTHFR (C677T variant): This is not considered a thrombophilia and is not recommended as a routine test when evaluating venous thrombosis.

📌 Clinical note: For most patients, inherited thrombophilia testing does not predict whether another clot will occur. Testing is therefore selected when the result could change decisions about treatment or prevention.

Risk may be higher when a person carries two genetic changes or two copies of the same change. This is assessed alongside their personal history and other factors.

Acquired thrombophilia

Acquired thrombophilia develops during life. Antiphospholipid syndrome (APS) is an important form: antiphospholipid antibodies are associated with an increased risk of venous or arterial thrombosis and pregnancy complications.

Cancer and its treatment, pregnancy, hormonal medications, inflammatory diseases, surgery, and immobilization may also increase the risk of thrombosis. These circumstances are assessed separately from thrombophilia test results.

Key point: Thrombophilia testing is not appropriate for everyone. It is useful when the result is expected to affect decisions about treatment, preventive medication, pregnancy, or hormone therapy.


What are the symptoms?

Symptoms of thrombosis

When thrombosis develops in a vein of the leg or arm, common signs include:

  • Swelling of one leg or arm
  • Pain, tenderness, or tightness, particularly in the calf or thigh
  • Warmth, redness, or a change in skin color in the affected area

Pulmonary embolism can occur without obvious signs of DVT. Symptoms include sudden difficulty breathing, chest pain that worsens with a deep breath or cough, a rapid heartbeat, dizziness, fainting, or coughing up blood. About half of people with DVT may have no noticeable symptoms.

Symptoms of thrombophilia

Thrombophilia itself usually causes no symptoms. Signs appear if a clot develops; in that case, the symptoms described above apply.


Warning signs

A swollen, painful leg needs prompt assessment. Symptoms of pulmonary embolism are a medical emergency and should not be left to resolve on their own.

⚠️ Seek immediate medical help if you develop sudden difficulty breathing, severe chest pain, fainting, coughing up blood, a very rapid heartbeat, or sudden, pronounced swelling of a limb.

Thrombophilia without a clot usually has no warning signs. If any of the symptoms above occur, urgent evaluation is needed whether or not thrombophilia has previously been diagnosed.


How are they diagnosed?

Diagnosis begins with symptoms, risk factors, and a physical examination. The doctor assesses the clinical probability of thrombosis and selects appropriate blood tests or imaging. No single symptom confirms a clot.

Diagnosing thrombosis

The following may be used to confirm or rule out an acute clot:

  • D-dimer: This can help rule out thrombosis in selected patients according to their clinical probability; an elevated result does not confirm the diagnosis by itself.
  • Doppler ultrasound: The main imaging test for diagnosing DVT in a limb.
  • CT pulmonary angiography: An important test when pulmonary embolism is suspected. Alternatives may be used in certain cases, depending on the clinical situation and contraindications.

Diagnosing thrombophilia

Thrombophilia tests are not used to confirm or rule out an acute clot. They look for a predisposition and are performed when the result is expected to influence clinical decisions.

Selected testing may include factor V Leiden, the prothrombin G20210A variant, antithrombin, protein C, protein S, and—when antiphospholipid syndrome is suspected—antiphospholipid antibodies. Timing matters: an acute illness and anticoagulants can affect some results, while genetic tests can be performed at any time.


How are they treated?

Treating thrombosis

Once thrombosis has occurred, treatment aims to stop the clot from growing, prevent new clots, and reduce the risk of complications:

  • Anticoagulants: Heparin, warfarin, or direct oral anticoagulants may be used according to the clinical situation to prevent clot growth and new clot formation.
  • Mechanical measures: Compression stockings or pneumatic devices may be used in selected situations.
  • Treatment for severe cases: Severe pulmonary embolism or a threatening thrombosis may require thrombolysis, catheter-based procedures, or other specialist interventions.

The duration of anticoagulation depends on the clot’s location and circumstances, whether it was provoked, the risk of recurrence, and the risk of bleeding.

Managing thrombophilia

Thrombophilia without thrombosis usually does not require permanent anticoagulation. A diagnosis of thrombophilia alone does not automatically mean lifelong treatment. The aim is to assess the need for prevention during periods of high risk.

Temporary preventive treatment may be needed after surgery, during hospitalization or immobilization, or during pregnancy or the postpartum period for people at increased risk.

If a person with thrombophilia develops thrombosis, the clot is treated according to the clinical situation. The type of thrombophilia may affect the choice of anticoagulant and the duration of treatment.


Possible complications

Complications of thrombosis

  • The most dangerous complication of DVT is pulmonary embolism. After DVT, some people develop post-thrombotic syndrome, with swelling, heaviness, pain, and skin changes. Difficulty breathing may persist after a pulmonary embolism; rarely, chronic thromboembolic pulmonary hypertension develops.
  • Thrombosis can recur, particularly if the first episode had no clear cause or risk factors remain.
  • Anticoagulants used for treatment increase the risk of bleeding, so their benefits and risks are reassessed regularly.

Complications of thrombophilia

Thrombophilia can be present without causing problems. Its significance lies in the increased risk of thrombosis. Some acquired forms, particularly antiphospholipid syndrome, may also be associated with arterial thrombosis or pregnancy complications.


Prevention and practical advice

Preventing thrombosis

Many episodes of venous thrombosis can be prevented. Measures depend on individual risk and circumstances:

  • Start moving as soon as it is safe after surgery or during recovery.
  • On long trips, get up and walk every 1–2 hours, move your ankles, and change position frequently.
  • Stay adequately hydrated and avoid sitting still for long periods.
  • Maintain a healthy weight, exercise regularly, and do not smoke.
  • Take prescribed anticoagulants exactly as directed and tell your doctor about any signs of bleeding.

Prevention for people with thrombophilia

Inherited thrombophilia cannot be prevented, but the risk of thrombosis can be reduced. For people with known thrombophilia, planning is particularly important during periods of increased risk:

  • Tell your doctor about thrombophilia or a previous clot before surgery, pregnancy, or estrogen use.
  • Follow recommended preventive measures, including medication when prescribed, movement, and healthy lifestyle habits during higher-risk situations.

When should you see a doctor?

Consult a hematologist if you have had a clot at a young age, without an apparent cause, in an unusual location, or more than once. Evaluation may also be useful when there is a strong history of thrombosis among first-degree relatives.

Seek advice before pregnancy, hormone therapy, estrogen-containing contraceptives, or a high-risk procedure if you have known thrombophilia or a significant personal or family history.


Why does timely assessment matter?

Thrombosis is the formation of a clot, while thrombophilia is an increased tendency to clot. Assessment should focus on symptoms, circumstances, and risk factors, rather than a genetic test alone.

Recognizing the signs of DVT and pulmonary embolism early, moving regularly, and using preventive treatment during high-risk periods can help prevent serious complications. A specialist determines the need for thrombophilia testing and the duration of anticoagulation individually.


Frequently asked questions


Is thrombosis dangerous?
Yes. DVT can cause a pulmonary embolism, which may be life-threatening. Prompt assessment and treatment reduce the risk of complications.

Does thrombophilia mean I will definitely develop a clot?
No. Thrombophilia increases the likelihood, but many people never develop a clot. A positive test does not mean a clot is certain, just as a negative result does not eliminate all risk.

Should I have a thrombophilia test?
Testing is not recommended for everyone. It makes sense when the result could change treatment or preventive measures, so the decision should be made with a specialist.

Does an MTHFR variant indicate a clotting risk?
Common MTHFR variants are not considered thrombophilia and are not recommended as part of routine testing for venous thrombosis.

Is thrombophilia always inherited?
No. There are inherited forms present from birth and acquired forms that develop during life.

What is the main test when thrombosis is suspected?
Doppler ultrasound is the main test for DVT in a limb. When pulmonary embolism is suspected, CT pulmonary angiography or an alternative selected according to the clinical situation may be used.

How long does anticoagulant treatment last?
It depends on whether the clot was provoked or unprovoked, the risk of recurrence, and the risk of bleeding. Treatment is time-limited in some cases and extended in others; the decision is individualized.


📅 Book a consultation with a hematologist

🩺 Learn about our checkup programs


📌 Reviewed by Dr. Irma Lapaj, Hematologist, Klinika Kajo.